Moderna | درآمد حاصل از بهره



Interest Income تغییر دادن تاریخ
Acadia Pharmaceuticals USD 7.01M 421K 2024-12
Agios Pharmaceuticals USD 18.02M 4.96M 2024-12
Alnylam Pharmaceuticals USD 31.02M 1.13M 2024-12
Arrowhead Research USD 7.6M 432K 2024-12
Biogen USD 18.5M 6.9M 2024-12
BioMarin Pharmaceutical USD 17.68M 373K 2024-12
Celltrion KRW 8.96B 1.67B 2024-09
Dianthus Therapeutics USD 3.99M 455K 2024-12
Gilead Sciences 85M 33M 2024-12
GlaxoSmithKline 32M 8M 2024-09
Incyte 128.71M 128.71M 2024-12
Ionis Pharmaceuticals -0.66 0.29 2024-12
Kangmei Pharma 4.31M 8.34M 2024-09
Knight Therapeutics CAD 2.46M 498K 2024-09
Moderna USD 91M 12M 2024-12
Pharma Mar 4.8M 6.4M 2024-12
Qiagen NV USD 15.09M 3.16M 2024-12
Regeneron Pharmaceuticals 8.12 3.42 2024-12
Sarepta Therapeutics USD 7.88M 298K 2024-12
Sartorius 54.9M 77.1M 2025-03
Tilray USD 12.83M 20.19M 2024-05
Ultragenyx Pharmaceutical USD 9.55M 1.18M 2024-12
United Therapeutics USD 49.3M 500K 2024-12
Vertex Pharmaceuticals USD 128.2M 4M 2024-12
Zhangzhou Pientzehuang Pharmaceutical 11.93M 13M 2024-09



Moderna درآمد حاصل از بهره - ارزش های فعلی، داده های تاریخی، پیش بینی، آمار، نمودار و تقویم اقتصادی - Apr 2025.